Home › Burkitt Lymphoma › Ohio › Cincinnati

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Cincinnati, OH

Isang pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cincinnati. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Nagre-recruitPhase 1

Cincinnati Children's Hospital, Cincinnati

Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06173518

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Nagre-recruitPhase 2

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03739814

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Cincinnati Children's Hospital Medical Center, Cincinnati

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04546399

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Nagre-recruitPhase 3

Cincinnati Children's Hospital Medical Center, Cincinnati

Edad 1 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07223021

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Nagre-recruitPhase 3

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi ang layo

Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT03150693

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Cincinnati Children's Hospital Medical Center, Cincinnati

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Nagre-recruitPhase 2

Cincinnati Children's Hospital Medical Center, Cincinnati

365 Days · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Cincinnati Children's Hospital Medical Center, Cincinnati

366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06124157

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Nagre-recruitPhase 3

University of Cincinnati Medical Center, Cincinnati

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07648264

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Nagre-recruitPhase 3

Cincinnati Children's Hospital Medical Center, Cincinnati

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Nagre-recruitPhase 2

Cincinnati Children's Hospital Medical Center, Cincinnati

Edad 7 hanggang 25 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05082519

Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

Nagre-recruitPhase 1

Cincinnati Children's Hospital Medical Center, Cincinnati

Edad 1 hanggang 39 · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT06863259

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Nagre-recruitPhase 1

University of Cincinnati, Cincinnati

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT06034275

Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Cincinnati

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.